BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
3.370
-0.090 (-2.60%)
At close: Jul 24, 2026, 4:00 PM EDT
3.310
-0.060 (-1.78%)
After-hours: Jul 24, 2026, 4:10 PM EDT
BioAtla Employees
BioAtla had 41 employees as of December 31, 2025. The number of employees decreased by 20 or -32.79% compared to the previous year.
Employees
41
Change (1Y)
-20
Growth (1Y)
-32.79%
Revenue / Employee
$48,780
Profits / Employee
-$1,234,561
Market Cap
5.59M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 41 | -20 | -32.79% |
| Dec 31, 2024 | 61 | -4 | -6.15% |
| Dec 31, 2023 | 65 | -1 | -1.52% |
| Dec 31, 2022 | 66 | 10 | 17.86% |
| Dec 31, 2021 | 56 | 20 | 55.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| CollPlant Biotechnologies | 39 |
| Aptevo Therapeutics | 33 |
| AIM ImmunoTech | 21 |
| Soligenix | 14 |
| NuCana | 12 |
| Purple Biotech | 10 |
| Alzamend Neuro | 6 |
BCAB News
- 7 weeks ago - BioAtla Proxy statement: Proxy filing - Filings
- 7 weeks ago - BioAtla Proxy statement: Proxy filing - Filings
- 2 months ago - Context Therapeutics enters license agreement amendment with BioAtla - TheFly
- 2 months ago - BioAtla Quarterly report: Q1 2026 - Filings
- 4 months ago - BioAtla trading halted, news pending - TheFly
- 4 months ago - BioAtla announces 50-for-1 share consolidation - TheFly
- 4 months ago - BioAtla Announces Share Consolidation - GlobeNewsWire
- 4 months ago - BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights - GlobeNewsWire